Kelly K. Gillespie Jennifer D. Oliva Response To: Drug Scheduling as Institutional Design by Matthew B. Lawrence,David E. Pozen Introduction Professors Matthew Lawrence and David...
As is often the case with newly de-SPACed companies, the stock has experienced some early volatility and technical selling pressure. That is normal imo....